Skip to main content
Premium Trial:

Request an Annual Quote

Admera AtheroGxOne NGS-Based Panel

Admera Health has launched its AtheroGxOne. It is a comprehensive NGS-based 84-gene panel aimed at identifying patients with a genetic signature for inherited premature coronary or atherosclerotic disease, such as Familial Hypercholesterolemia or Mature Onset Diabetes of the Young. The panel completes the company's Cardiovascular Test Portfolio, which also includes CardioGxOne and PGxCardio.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.